Zanjie Feng
Guiyang, 550001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Aucubin Inhibits Liver Cancer via HMGB1-mediated Inactivation of the PI3K/AKT/mTOR Signaling Pathway.
Journal: Recent patents on anti-cancer drug discovery
Published: July 14, 2025
Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways.
Journal: Frontiers in oncology
Published: February 14, 2025
Network pharmacology and molecular docking elucidate potential mechanisms of Eucommia ulmoides in hepatic ischemia-reperfusion injury.
Journal: Scientific reports
Published: August 24, 2023
Chlorogenic Acid Alleviates Hepatic Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress, Inflammation, and Mitochondria-Mediated Apoptosis In Vivo and In Vitro.
Journal: Inflammation
Published: September 25, 2022
Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and Cell Heterogeneity in the Microenvironment.
Journal: International journal of general medicine
Published: September 16, 2021
Aucubin Attenuates Liver Ischemia-Reperfusion Injury by Inhibiting the HMGB1/TLR-4/NF-κB Signaling Pathway, Oxidative Stress, and Apoptosis.
Journal: Frontiers in pharmacology
Published: March 19, 2020
High-Throughput Docking and Molecular Dynamics Simulations towards the Identification of Potential Inhibitors against Human Coagulation Factor XIIa.
Journal: Computational and mathematical methods in medicine
Published: January 12, 2020
Anti-Inflammatory and Antioxidant Effect of Eucommia ulmoides Polysaccharide in Hepatic Ischemia-Reperfusion Injury by Regulating ROS and the TLR-4-NF-κB Pathway.
Journal: BioMed research international
Published: December 18, 2019
Expression and purification of recombinant serine protease domain of human coagulation factor XII in Pichia pastoris.
Journal: Bioscience, biotechnology, and biochemistry
Published: May 24, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026